These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 8655968)

  • 21. Prevalence of hepatitis C virus antibodies in the general population and in selected groups of patients in Limoges, France.
    Ranger S; Martin P; Roussanne MC; Denis F
    Gut; 1993; 34(2 Suppl):S50-1. PubMed ID: 7686115
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Prevalence of hepatitis C virus antibodies in hospital personnel].
    Cağatay M; Tülek N; Köksalan H; Mert A
    Mikrobiyol Bul; 1992 Jul; 26(3):242-7. PubMed ID: 1382216
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of antibodies to hepatitis C virus in Greek patients with chronic liver disease.
    Papatheodoridis GV; Delladetsima I; Koutelou M; Katsoulidou A; Hatzakis A; Tassopoulos NC
    J Hepatol; 1994 Jun; 20(6):843. PubMed ID: 7523484
    [No Abstract]   [Full Text] [Related]  

  • 24. Cryoglobulinemia and hepatatrophic viruses.
    Baker AL
    Hepatology; 1993 Sep; 18(3):698-700. PubMed ID: 7689532
    [No Abstract]   [Full Text] [Related]  

  • 25. Inconclusive hepatitis C virus antibody results in African sera.
    Hyams KC; Okoth FA; Tukei PM; Vallari DS; Morrill JC; Long G; Bansal J; Constantine N
    J Infect Dis; 1993 Jan; 167(1):254-5. PubMed ID: 7678108
    [No Abstract]   [Full Text] [Related]  

  • 26. Seropositivity to hepatitis C virus in Tunisian haemodialysis patients.
    Jemni S; Ikbel K; Kortas M; Mahjoub J; Ghachem L; Bidet JM; Boukef K
    Nouv Rev Fr Hematol (1978); 1994 Oct; 36(5):349-51. PubMed ID: 7534398
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatitis C virus infection in chronic hepatitis B virus carriers.
    Fattovich G; Tagger A; Brollo L; Giustina G; Pontisso P; Realdi G; Alberti A; Ruol A
    J Infect Dis; 1991 Feb; 163(2):400-2. PubMed ID: 1846394
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Prevalence of anti-hepatitis C antibody carriers in a military population engaged in overseas missions].
    Martet G; Merouze F; Thomas C; Morillon M; Klotz F; Laroche R
    Med Trop (Mars); 1994; 54(1):88. PubMed ID: 7515143
    [No Abstract]   [Full Text] [Related]  

  • 29. Concomitant high prevalence of hepatitis C virus antibodies and hepatitis B virus markers in a small village of the Amazon Region, Mato Grosso State, Brazil.
    Souto FJ; Fontes CJ; Gaspar AM; Paraná R; Lyra LG
    Rev Inst Med Trop Sao Paulo; 1996; 38(3):221-3. PubMed ID: 9163988
    [No Abstract]   [Full Text] [Related]  

  • 30. [The epidemiology of hepatitis C].
    Rădulescu A; Bucşan I; Rafiroiu C; Suteu O
    Bacteriol Virusol Parazitol Epidemiol; 1993; 38(1-2):85-9. PubMed ID: 9132119
    [No Abstract]   [Full Text] [Related]  

  • 31. Hepatitis C virus antibody in acute and chronic liver diseases in India.
    Gupta H; Irshad M; Joshi YK; Acharya SK; Tandon BN
    Scand J Infect Dis; 1990; 22(5):627. PubMed ID: 2175450
    [No Abstract]   [Full Text] [Related]  

  • 32. [Antibodies against viral hepatitis C in groups at risk].
    Roşiu N; Pop O; Claici C; Cioflec D; Novac VP; Strein R; Nicoară E; Bodea A; Boieriu E; Niculescu V
    Bacteriol Virusol Parazitol Epidemiol; 1994; 39(1-2):84-7. PubMed ID: 7981534
    [No Abstract]   [Full Text] [Related]  

  • 33. [The prevalence of antibodies to the hepatitis C virus (HCV) in patients with post-transfusional hepatitis and blood donors in Moldova].
    Iancu L; Turcu T; Apetrei C; Porumb S; Dimitriu S; Donţu G; Mândru R; Moraru E; Duca M
    Bacteriol Virusol Parazitol Epidemiol; 1993; 38(1-2):76-80. PubMed ID: 9132116
    [No Abstract]   [Full Text] [Related]  

  • 34. Prevalence and presentation of hepatitis C related chronic liver disease in southern India.
    Issar SK; Ramakrishna BS; Ramakrishna B; Christopher S; Samuel BU; John TJ
    J Trop Med Hyg; 1995 Jun; 98(3):161-5. PubMed ID: 7783272
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The epidemiology of antibody to hepatitis C in Egypt.
    Hibbs RG; Corwin AL; Hassan NF; Kamel M; Darwish M; Edelman R; Constantine NT; Rao MR; Khalifa AS; Mokhtar S
    J Infect Dis; 1993 Sep; 168(3):789-90. PubMed ID: 8394867
    [No Abstract]   [Full Text] [Related]  

  • 36. [A seroepidemiological investigation on HCV infection among population in Tianjin area].
    Lu C
    Zhonghua Liu Xing Bing Xue Za Zhi; 1993 Jun; 14(3):147-50. PubMed ID: 8221836
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The prevalence of antibodies directed against hepatitis C virus in hepatocellular carcinoma: relation to hepatitis B virus, Pugh's score, Okuda's staging and survival].
    Giovannini M; Seitz JF; Pingannaud MP; Sauvan R; Rossi I; Pasquier J; Gauthier A
    Ann Gastroenterol Hepatol (Paris); 1991; 27(1):36. PubMed ID: 1851405
    [No Abstract]   [Full Text] [Related]  

  • 38. [The incidence of detecting antibodies to the hepatitis C virus in children in specialized children's institutions].
    Kuzin SN; Viazov SO; Shakhgil'dian IV; Buriev AIa; Savin EA; Orlova NG; Kalibatova LA; Tlenkopachev RS; Bryzgalov SP; Petrova OE
    Vopr Virusol; 1992; 37(2):96-7. PubMed ID: 1332263
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of control group in studies of intrafamiliar spread of hepatitis C virus.
    Riestra S; Fernández E; García S; Rodríguez M; Rodrigo L
    Infection; 1995; 23(5):314. PubMed ID: 8557396
    [No Abstract]   [Full Text] [Related]  

  • 40. Antibodies to hepatitis C virus and response to interferon treatment in non-A, non-B chronic hepatitis.
    Taliani G; Lecce R; Clementi C; Furlan C; De Bac C
    J Hepatol; 1991 Mar; 12(2):264-5. PubMed ID: 1646837
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.